Literature DB >> 26009002

Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value.

Hugh Kearney1, David H Miller1, Olga Ciccarelli1.   

Abstract

Multiple sclerosis (MS) is an inflammatory disorder of the CNS that affects both the brain and the spinal cord. MRI studies in MS focus more often on the brain than on the spinal cord, owing to the technical challenges in imaging this smaller, mobile structure. However, spinal cord abnormalities at disease onset have important implications for diagnosis and prognosis. Furthermore, later in the disease course, in progressive MS, myelopathy becomes the primary characteristic of the clinical presentation, and extensive spinal cord pathology--including atrophy, diffuse abnormalities and numerous focal lesions--is common. Recent spinal cord imaging studies have employed increasingly sophisticated techniques to improve detection and quantification of spinal cord lesions, and to elucidate their relationship with physical disability. Quantitative MRI measures of cord size and tissue integrity could be more sensitive to the axonal loss and other pathological processes in the spinal cord than is conventional MRI, putting quantitative MRI in a key role to elucidate the association between disability and spinal cord abnormalities seen in people with MS. In this Review, we summarize the most recent MS spinal cord imaging studies and discuss the new insights they have provided into the mechanisms of neurological impairment. Finally, we suggest directions for further and future research.

Entities:  

Mesh:

Year:  2015        PMID: 26009002     DOI: 10.1038/nrneurol.2015.80

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  123 in total

1.  Diffuse signal abnormalities in the spinal cord in multiple sclerosis: direct postmortem in situ magnetic resonance imaging correlated with in vitro high-resolution magnetic resonance imaging and histopathology.

Authors:  Elisabeth Bergers; Joost C J Bot; Paul van der Valk; Jonas A Castelijns; Geert J Lycklama a Nijeholt; Wouter Kamphorst; Chris H Polman; Erwin L A Blezer; Klaas Nicolay; Rivka Ravid; Frederik Barkhof
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

2.  Spinal cord neuronal pathology in multiple sclerosis.

Authors:  Christopher P Gilmore; Gabriele C DeLuca; Lars Bö; Trudy Owens; James Lowe; Margaret M Esiri; Nikos Evangelou
Journal:  Brain Pathol       Date:  2008-12-19       Impact factor: 6.508

3.  Cervical cord area measurement using volumetric brain magnetic resonance imaging in multiple sclerosis.

Authors:  Zheng Liu; Özgür Yaldizli; Matteo Pardini; Varun Sethi; Hugh Kearney; Nils Muhlert; Claudia Wheeler-Kingshott; David H Miller; Declan T Chard
Journal:  Mult Scler Relat Disord       Date:  2014-11-18       Impact factor: 4.339

4.  Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients.

Authors:  Paola Valsasina; Maria A Rocca; Federica Agosta; Beatrice Benedetti; Mark A Horsfield; Antonio Gallo; Marco Rovaris; Giancarlo Comi; Massimo Filippi
Journal:  Neuroimage       Date:  2005-03-31       Impact factor: 6.556

Review 5.  The current state-of-the-art of spinal cord imaging: applications.

Authors:  C A Wheeler-Kingshott; P W Stroman; J M Schwab; M Bacon; R Bosma; J Brooks; D W Cadotte; T Carlstedt; O Ciccarelli; J Cohen-Adad; A Curt; N Evangelou; M G Fehlings; M Filippi; B J Kelley; S Kollias; A Mackay; C A Porro; S Smith; S M Strittmatter; P Summers; A J Thompson; I Tracey
Journal:  Neuroimage       Date:  2013-07-14       Impact factor: 6.556

6.  Cervical cord FMRI abnormalities differ between the progressive forms of multiple sclerosis.

Authors:  Paola Valsasina; Maria A Rocca; Martina Absinta; Federica Agosta; Domenico Caputo; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2011-08-25       Impact factor: 5.038

7.  Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial.

Authors:  X Lin; C R Tench; B Turner; L D Blumhardt; C S Constantinescu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

8.  Early MRI in optic neuritis: the risk for disability.

Authors:  J K Swanton; K T Fernando; C M Dalton; K A Miszkiel; D R Altmann; G T Plant; A J Thompson; D H Miller
Journal:  Neurology       Date:  2009-02-10       Impact factor: 9.910

9.  Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination.

Authors:  J C J Bot; F Barkhof; C H Polman; G J Lycklama à Nijeholt; V de Groot; E Bergers; H J Ader; J A Castelijns
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

10.  Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions.

Authors:  N Evangelou; G C DeLuca; T Owens; M M Esiri
Journal:  Brain       Date:  2004-11-17       Impact factor: 13.501

View more
  63 in total

1.  Gradient nonlinearity effects on upper cervical spinal cord area measurement from 3D T1 -weighted brain MRI acquisitions.

Authors:  Nico Papinutto; Rohit Bakshi; Antje Bischof; Peter A Calabresi; Eduardo Caverzasi; R Todd Constable; Esha Datta; Gina Kirkish; Govind Nair; Jiwon Oh; Daniel Pelletier; Dzung L Pham; Daniel S Reich; William Rooney; Snehashis Roy; Daniel Schwartz; Russell T Shinohara; Nancy L Sicotte; William A Stern; Ian Tagge; Shahamat Tauhid; Subhash Tummala; Roland G Henry
Journal:  Magn Reson Med       Date:  2017-06-15       Impact factor: 4.668

Review 2.  Secondary Progressive Multiple Sclerosis: Definition and Measurement.

Authors:  Domenico Plantone; Floriana De Angelis; Anisha Doshi; Jeremy Chataway
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

3.  Automatic Spinal Cord Gray Matter Quantification: A Novel Approach.

Authors:  C Tsagkas; A Horvath; A Altermatt; S Pezold; M Weigel; T Haas; M Amann; L Kappos; T Sprenger; O Bieri; P Cattin; K Parmar
Journal:  AJNR Am J Neuroradiol       Date:  2019-08-22       Impact factor: 3.825

Review 4.  Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis.

Authors:  A Nandoskar; J Raffel; A S Scalfari; T Friede; R S Nicholas
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

5.  Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis.

Authors:  Noriko Isobe; Anisha Keshavan; Pierre-Antoine Gourraud; Alyssa H Zhu; Esha Datta; Regina Schlaeger; Stacy J Caillier; Adam Santaniello; Antoine Lizée; Daniel S Himmelstein; Sergio E Baranzini; Jill Hollenbach; Bruce A C Cree; Stephen L Hauser; Jorge R Oksenberg; Roland G Henry
Journal:  JAMA Neurol       Date:  2016-07-01       Impact factor: 18.302

6.  Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.

Authors:  Dominique Eden; Charley Gros; Atef Badji; Sara M Dupont; Benjamin De Leener; Josefina Maranzano; Ren Zhuoquiong; Yaou Liu; Tobias Granberg; Russell Ouellette; Leszek Stawiarz; Jan Hillert; Jason Talbott; Elise Bannier; Anne Kerbrat; Gilles Edan; Pierre Labauge; Virginie Callot; Jean Pelletier; Bertrand Audoin; Henitsoa Rasoanandrianina; Jean-Christophe Brisset; Paola Valsasina; Maria A Rocca; Massimo Filippi; Rohit Bakshi; Shahamat Tauhid; Ferran Prados; Marios Yiannakas; Hugh Kearney; Olga Ciccarelli; Seth A Smith; Constantina Andrada Treaba; Caterina Mainero; Jennifer Lefeuvre; Daniel S Reich; Govind Nair; Timothy M Shepherd; Erik Charlson; Yasuhiko Tachibana; Masaaki Hori; Kouhei Kamiya; Lydia Chougar; Sridar Narayanan; Julien Cohen-Adad
Journal:  Brain       Date:  2019-03-01       Impact factor: 13.501

7.  MRI Atlas-Based Measurement of Spinal Cord Injury Predicts Outcome in Acute Flaccid Myelitis.

Authors:  D B McCoy; J F Talbott; Michael Wilson; M D Mamlouk; J Cohen-Adad; Mark Wilson; J Narvid
Journal:  AJNR Am J Neuroradiol       Date:  2016-12-15       Impact factor: 3.825

Review 8.  MRI and multiple sclerosis-the evolving role of MRI in the diagnosis and management of MS: a clinician's perspective.

Authors:  H Kearney; A M Cahalane; R P Killeen; C McGuigan
Journal:  Ir J Med Sci       Date:  2017-10-10       Impact factor: 1.568

9.  Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis.

Authors:  Itzy E Morales Pantoja; Che-Lin Hu; Nora I Perrone-Bizzozero; Jianzheng Zheng; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2016-09-19       Impact factor: 5.372

10.  Spinal cord diffusion tensor imaging in patients with sensory neuronopathy.

Authors:  Raphael Fernandes Casseb; Jean Levi Ribeiro de Paiva; Lucas Melo Teixeira Branco; Alberto Rolim Muro Martinez; Fabiano Reis; José Carlos de Lima-Junior; Gabriela Castellano; Marcondes Cavalcante França Junior
Journal:  Neuroradiology       Date:  2016-08-25       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.